Resources

Exubera gets pulled from the market, Lilly discontinues AIR. Why is this happening. Why would patients want Ouch over Ouch less? Richard Dolinar, MD, Senior Fellow Healthcare Policy, Heartland Institute, thinks he knows what happened. Click here to find out what he figured out.

By Sheri Colberg, Ph.D., FACSM   Dr. Sheri Colberg, Ph.D., FACSM continues talking about Resistance Training. This week Upper-body resistance training exercises: Chest press and shoulder press. Print this out to go with last week’s lesson.

Everyone seems to agree that there is little in the ONTARGET megatrial, presented at the American College of Cardiology (ACC) 57th Annual Scientific Session, to quibble about and that it shows clear results: doctors now have a choice of an ACE inhibitor or angiotensin receptor blocker (ARB) in high-risk CHD/diabetes …

The diabetes drug pioglitazone (Actos) led to a significant slowing of atherosclerosis, albeit small, as measured by intravascular ultrasound (IVUS), compared with glimepiride, according to the results of a new study.

Sanofi-Aventis SA’s weight-loss drug rimonabant failed to slow heart disease by a key measure in obese patients with fat around the middle, and it significantly raised the risk of anxiety and depression.

Poor glycemic control is linked to the development of microalbuminuria in childhood-onset type 1 diabetes.

Diabetics are at an increased risk when it comes to developing heart attacks and strokes. A new study finds lowering suggested targets for blood pressure and cholesterol levels beyond national guidelines may help prevent certain risk factors

Results from a new study reinforces the concept that the danger level for diabetics for heart attacks is the same as non-diabetics who already have had a heart attack.

Mast cell stabilizing therapy with topical cromolyn can reverse early injection-site lipoatrophy induced by human insulin analogs, and prevent further lesions.

For patients at risk of metabolic syndrome and type 2 diabetes, the Chinese exercises Tai Chi and Qigong may improve clinical parameters associated with the conditions, two small studies suggested.